top of page
System and method for medical literature monitoring of adverse drug reactions - US Patent 2022/0336111 (October 2022)
Validation and Transparency in AI for pharmacovigilance: a case study applied to The medical literature monitoring of adverse events. Bruno Ohana, Jack Sullivan and Nicole Baker (December 2021) ArXiv 2201.00692
Reducing screening workload in medical literature monitoring with machine learning, Bruno Ohana, DIA Regulatory Science Forum (September 2020)
Stay tuned for more great content by the Biologit team in our blog, from AI regulatory frameworks, applying AI for productive medical literature monitoring and much more.
bottom of page